EUVIMEDEUVIMED entdecken
Crossref

Nesfatin-1, a new appetite peptide in patients with fatty liverdisease associated with metabolic dysfunction MASLD

Aldona Wierzbicka-Rucińska, Monika Łubianka, Ilona Kuchnio, Bernadetta Jakubowicz

Diagnostyka Laboratoryjna · 31.12.2025 · 61 (4) · 207-215

DOI: 10.5604/01.3001.0055.6657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostyka Laboratoryjna, erschienen am 31.12.2025. Verfasst von Aldona Wierzbicka-Rucińska und 3 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a civilization disease that affects children, teenagers, and adultsalike. In most cases, it is the result of excessive food intake, which leads to metabolic disorders such as fatty liver disease with metabolic dysfunction (MASLD), type 2 diabetes, andhypertension. The amount and quality of food intake are influenced by socio-economic status, education,and also by disorders in the secretion of anorectic factors, such as nesfatin-1. In 2006, presence of nesfatin-1 was observed in neurons of various hypothalamic centers involved in the regulation of food intake. Thispeptide affects oxytocin-secreting cells and stimulates its secretion. In the mouse model, administration ofoxytocin resulted in a decrease in appetite. Nesfatin-1 plays a significant role in the digestive system, in additionto its effects on cardiovascular function, sleep regulation, and reproductive function. It participates inthe metabolic control of the body and water intake, the modulation of energy balance and body temperature.Nesfatin-1 may be an important element in the treatment of obesity in the future.

Zitieren

APA

Wierzbicka-Rucińska, A., Łubianka, M., Kuchnio, I., & Jakubowicz, B. (2025). Nesfatin-1, a new appetite peptide in patients with fatty liverdisease associated with metabolic dysfunction MASLD. Diagnostyka Laboratoryjna, 61(4), 207-215. https://doi.org/10.5604/01.3001.0055.6657

Vancouver

Wierzbicka-Rucińska A, Łubianka M, Kuchnio I, Jakubowicz B. Nesfatin-1, a new appetite peptide in patients with fatty liverdisease associated with metabolic dysfunction MASLD. Diagnostyka Laboratoryjna. 2025;61(4):207-215. doi:10.5604/01.3001.0055.6657

BibTeX
@article{WierzbickaRuciska2025,
  author = {Wierzbicka-Rucińska, Aldona and Łubianka, Monika and Kuchnio, Ilona and Jakubowicz, Bernadetta},
  title = {Nesfatin-1, a new appetite peptide in patients with fatty liverdisease associated with metabolic dysfunction MASLD},
  journal = {Diagnostyka Laboratoryjna},
  year = {2025},
  volume = {61},
  number = {4},
  pages = {207--215},
  doi = {10.5604/01.3001.0055.6657}
}
Kostenlos starten →